Legal Representation
Attorney
Scott D. Woldow
USPTO Deadlines
Next Deadline
144 days remaining
NOA E-Mailed - SOU Required
Due Date
December 03, 2025
Extension Available
Until June 03, 2026
Application History
12 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 3, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 13, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 13, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Mar 13, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Mar 13, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Mar 13, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Mar 10, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 12, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 12, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of immuno deficiency disorders; intravenous immunoglobulins for use in the treatment of immuno deficiency disorders and in immune replacement therapy; Pharmaceutical preparations for the treatment of dermatomyositis, inflammatory diseases and inflammatory conditions, muscle conditions and skin conditions; pharmaceutical preparations for the treatment of skin rash, weight loss, fever, lung conditions, light sensitivity, calcium deposits, and cardiovascular conditions; pharmaceutical preparations for the treatment of inflammatory myopathy and muscular conditions
Classification
International Classes
005